Successful re-introduction of lamotrigine after initial rash

نویسندگان

  • F.M.C. Besag
  • G.Y.T. Ng
  • F. Pool
چکیده

The aim of this study was to determine whether lamotrigine can be re-introduced safely and with a benefit in young people who previously had a mild rash associated with the first introduction of this drug. In the first 150 young people (5-19 years old) treated with lamotrigine in a special centre for epilepsy, seven developed a mild rash soon after starting the drug. In none of these cases was the rash severe, nor was there any mucous membrane involvement. The lamotrigine was stopped immediately when the rash was identified and was subsequently re-introduced, using a special very-low-dose-escalation regime, starting with 0.1 mg /day total daily dose, after periods ranging from 47 to 236 days. It was possible to re-introduce the lamotrigine without recurrence of persistent rash and without any adverse effects in all seven cases. The re-introduction of lamotrigine was associated with improvement in five of the seven cases. It is recommended that lamotrigine is stopped as soon as any rash attributable to the drug develops but it may be possible to re-introduce the drug after mild rash using a very-slow-dose-escalation regime, with a benefit in at least some cases.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Rechallenge with lamotrigine after initial rash

Eight patients rechallenged with lamotrigine after initial exposure which resulted in a skin rash are reported. On reintroduction of the lamotrigine, six of the patients had no recurrence of the rash. Of the other two patients, one had the occurrence of a mild fluctuating and qualitatively different skin rash on rechallenge. The other patient had developed a dose-related rash on initial challen...

متن کامل

Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature.

OBJECTIVE To investigate the safety of rechallenge with lamotrigine after an initial rash in patients with refractory bipolar depression. DESIGN 1) Prospective, open-label case series in a private practice setting. Patients who developed an initial rash on lamotrigine and were refractory to other treatments were offered rechallenge with the drug using very-low-dose titration (5mg every other ...

متن کامل

Lamotrigine rechallenge after a skin rash. A combined study of open cases and a meta-analysis.

OBJECTIVE To determine the safety of lamotrigine rechallenge after a first episode of skin rash in bipolar patients. METHOD An open cases prospective study was conducted with patients who, developed a skin rash when first treated with lamotrigine, were refractory to other treatments, and were offered lamotrigine rechallenge using a different dose titration. Additionally a review was performed...

متن کامل

Microsoft Word - DRM307BF

Lamotrigine Toxic epidermal necrolysis Valproic acid D. Vukelic, MD, University Hospital for Infectious Diseases ‘Dr. Fran Mihalević, Mirogojska cesta 8, CRO-41000 Zagreb (Croatia) Cutaneous rash is one of the commonest adverse events associated with lamotrigine, especially among patients already taking valproic acid. The risk of developing severe skin reactions including toxic epidermal necrol...

متن کامل

Lamotrigine in adolescent mood disorders: a retrospective chart review.

INTRODUCTION Treatment nonresponse in adolescent mood disorders is a major public health problem, as mood disorders in youth are associated with significant mortality by suicide, protracted course of illness, and recurrence into adulthood. Three studies with small sample sizes exist for lamotrigine in youth mood disorders. However, the risk of serious rash has limited its use in youth mood diso...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Seizure

دوره 9  شماره 

صفحات  -

تاریخ انتشار 2000